Vimarsana
Biggest News Aggregation in the World

Page 3 - Sol 2 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sol 2. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sol 2 Today - Breaking & Trending Today

USCIS Settlement Requires Adjudication of H-4 EAD and L-2 - Vimarsana News

USCIS Settlement Requires Adjudication of H-4 EAD and L-2

U.S. Department of Homeland Security DHS reached a settlement in Edakunni v. Mayorkas, which restructures U.S. Citizenship and Immigration Services’ USCIS adjudication policies for H-4 and L-2 dependents, including applicable employment authorization documents EADs.

Dupilumab Reduces AD Severity Biomarkers in Children, Adolescents - Vimarsana News

Dupilumab Reduces AD Severity Biomarkers in Children, Adolescents

In pediatric patients with atopic dermatitis, a new study found that treatment with dupilumab significantly reduces symptoms and biomarkers related to disease severity.

Sanofi hits reset on drug from $2.5B deal after 'lower than projected' efficacy in trials - Vimarsana News

Sanofi hits reset on drug from $2.5B deal after 'lower than projected' efficacy in trials

Sanofi did not see the efficacy it wanted in mid-stage tests of a cytokine therapy from its $2.5 billion acquisition of Synthorx. While the pharmaceutical giant isn’t giving up on the drug, it said it will restart the molecule in a new Phase 1/2 program, a setback that will lead to a €1.6 billion financial writedown.

"Co-axial printing of growth factor-laden microspheres for pancreatic i" by Ane Urigoitia Asua - Vimarsana News

"Co-axial printing of growth factor-laden microspheres for pancreatic i" by Ane Urigoitia Asua

Type I diabetes is an autoimmune disease affecting millions of people in the world. It occurs when the pancreas cannot produce insulin, resulting in episodes of hyperglycaemia that can lead to heart attacks, renal failure, or death. The main cause is the auto destruction of beta cells that produce insulin, located in the pancreatic islets (or islets of Langerhans). Current treatments include insulin injections that decrease the blood glucose level. However, it can sometimes generate hypoglycaemia or insulin resistance on the patients. Bioprinting allows controlled engineering of pancreatic isl...

Source: uow.edu.au
Related Topics:
Co AxialSol 2
NASA's Inspector General's Report on SLS Rocket's Mobile Launcher Shows Project is Delayed, Pushing $1 Billion in Costs - Vimarsana News

NASA's Inspector General's Report on SLS Rocket's Mobile Launcher Shows Project is Delayed, Pushing $1 Billion in Costs

NASA already has its own mobile launcher for its Space Launch System (SLS) rocket. However, the space agency intends to replace this $668.7 million launcher after only three missions.